Related Articles
Triple‑negative breast cancer cells that survive ionizing radiation exhibit an Axl‑dependent aggressive radioresistant phenotype
Anti‑Axl monoclonal antibodies attenuate the migration of MDA‑MB‑231 breast cancer cells
Loss of miR‑873 contributes to gemcitabine resistance in triple‑negative breast cancer via targeting ZEB1
PD‑L1/PD‑1 blockade in breast cancer: The immunotherapy era (Review)
Inhibition of miR‑483‑5p improves the proliferation, invasion and inflammatory response of triple‑negative breast cancer cells by targeting SOCS3